We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

45 hedge funds and large institutions have $65M invested in ALPS Medical Breakthroughs ETF in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

595% more capital inflows, than outflows

Capital inflows: $18.2M | Capital outflows: $2.62M

217% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 6

146% more call options, than puts

Call options by funds: $917K | Put options by funds: $373K

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

7% more funds holding

Funds holding: 42 → 45 (+3)

4.23% more ownership

Funds ownership: 25.58% → 29.8% (+4.2%)

Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
6
Closed
7
Calls
$917​K
Puts
$373​K
Net Calls
+$544​K
Net Calls Change
-⁠$168​K

SBIO Hedge Fund Activity: Q2 2018 in Review

45 of the 4,387 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2018, worth a combined $65M — up 44% from $45.1M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SBIO positions and 7 closed out — a net gain of 3 holders — while 19 added to existing stakes and 6 trimmed.

The largest buyer was Bank of America, adding an estimated $5.6M. The largest seller was Virtu Financial, exiting entirely with an estimated $1.45M sold.

  • 45 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2018, up from 42 in Q1 2018.
  • Funds reported $65M of ALPS Medical Breakthroughs ETF stock for Q2 2018, up 44% quarter-over-quarter.
  • 10 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2018 and 7 closed out, a net change of +3 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q2 2018 was Bank of America, an estimated $5.6M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q2 2018 was Virtu Financial, an estimated $1.45M sold.

Based on aggregated 13F filings for Q2 2018.